Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.

Not the CRISPR Rival We Hoped For

Nature Biotechnology announced that they were officially retracting a paper published in May 2016 last week, which claimed to demonstrate how a novel technique could perform gene editing in mammalian cells.